Article Information
History
- April 22, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 22, 2020 - 21:15).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- David RM Smith, (MSc)*,1,2,3,#,
- Audrey Duval, (PhD)*,1,
- Koen B Pouwels, (PhD)4,5,
- Didier Guillemot, (PhD)1,2,6,
- Jérôme Fernandes, (MD)7,
- Bich-Tram Huynh, (MD)1,
- Laura Temime, (PhD)§,3,8,
- Lulla Opatowski, (PhD)§,1,2 and
- on behalf of the AP-HP/Universities/Inserm COVID-19 research collaboration
- 1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
- 2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
- 3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
- 4Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- 5The National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
- 6AP-HP, Paris Saclay, Public Health, Medical Information, Clinical Research, Le Kremlin-Bicêtre, France
- 7Clinique de soins de suite et réadaptation, Choisy-Le-Roi, France
- 8PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
- ↵#Corresponding author:
David Smith (david.smith{at}pasteur.fr), 25 rue du Dr Roux, Paris 75015, France
Posted April 22, 2020.
How best to use limited tests? Improving COVID-19 surveillance in long-term care
